Though the CD200:CD200R1 axis has been implicated to play a role in transplant tolerance (Gorczynski, 2001; Yu, Chen, & Gorczynski, 2013) , one can speculate that disrupting this relationship in posttransplant patients, or other immunosuppressed patients may actually have short-term benefit under conditions where viral infections can become an issue.